Related Experiment Video
Updated: Mar 6, 2026

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
7.0K
Pathway cross-talk network analysis identifies critical pathways in neonatal sepsis
Yu-Xiu Meng1, Quan-Hong Liu2, Deng-Hong Chen3
1Department of Neonatology, First People's Hospital of Jining, Jining, Shandong 272011, PR China.
Computational Biology and Chemistry
|March 16, 2017
Summary
Neonatal sepsis is a major threat. This study identified 8 critical pathways involved in neonatal sepsis using pathway cross-talk analysis, offering new insights for diagnosis and therapy.
Area of Science:
- Neonatal research
- Systems biology
- Infectious disease pathology
Background:
- Neonatal sepsis poses significant global health challenges, impacting infant morbidity and mortality.
- Understanding the complex pathogenesis of neonatal sepsis is crucial for improving clinical outcomes.
- Pathway cross-talk analysis offers a novel approach to deciphering the driving forces behind bacterial sepsis in neonates.
Purpose of the Study:
- To explore critical pathways in neonatal sepsis progression.
- To utilize pathway cross-talk analysis for identifying key molecular mechanisms.
- To enhance understanding of neonatal sepsis pathogenesis.
Main Methods:
- Integrated neonatal transcriptome, pathway, and protein-protein interaction data.
- Constructed a disease pathway cross-talk network for neonatal sepsis.
- Employed the attract method and rank product (RP) algorithm with impact factor (IF) for pathway identification.
Main Results:
- A pathway cross-talk network was built using 1249 significant pathway cross-talks.
- Identified 47 dysregulated pathways via the attract method and 20 pathways with RP<0.01.
- Pinpointed 8 common critical pathways with high impact factors and statistical significance.
Conclusions:
- Systematically identified 8 critical pathways implicated in neonatal sepsis.
- These pathways are potentially key to host response during infection.
- Findings hold significant value for advancing neonatal sepsis diagnosis and therapeutic strategies.

